211678-96-5

Usage

Uses

Used in Pharmaceutical Industry:
3-Chloroisonicotinic acid ethyl ester is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs. Its chemical properties allow it to be a versatile component in the creation of various medicinal compounds, enhancing the therapeutic potential of resulting pharmaceuticals.
Used in Agrochemical Industry:
In the agrochemical sector, 3-CHLOROISONICOTINIC ACID ETHYL ESTER is employed as a precursor in the production of agrochemicals, such as pesticides and herbicides. Its role in these applications is to provide a foundation for the synthesis of compounds that can effectively control, repel, or kill pests and weeds, thereby contributing to improved crop yields and agricultural productivity.
Used as a Building Block in Organic Synthesis:
3-Chloroisonicotinic acid ethyl ester is used as a building block for the synthesis of other organic compounds due to its reactivity and functional groups. This makes it a valuable component in the development of new chemical entities with potential applications across various industries, including but not limited to pharmaceuticals, materials science, and specialty chemicals.

InChI:InChI=1/C8H8ClNO2/c1-2-12-8(11)6-3-4-10-5-7(6)9/h3-5H,2H2,1H3

Upstream product

• 64-17-5 ethanol 
• 88912-27-0 3-chloro-isonicotinic acid 

Relevant academic research and scientific papers

NEW ANTHELMINTIC COMPOUNDS

The present invention relates to novel compounds of general formula (I) with A being A1 or A2, and in which T, X, Y, Ro, R1, R10 and R11 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients.

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

The invention relates to heterocyclic amide derivatives of formula (I), wherein R1, R2, R3, R4, R5, X, Y and n are as defined in the description, their preparation and their use as pharmaceutically active compounds.

HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

The invention relates to heterocyclic amide derivatives of formula (I), wherein R1, R2, R3, R4, R5, X, Y and n are as defined in the description, their preparation and their use as pharmaceutically active compounds.

AZA-BENZOTHIOPHENYL COMPOUNDS AND METHODS OF USE

The invention relates to azabenzothiophenyl compounds of Formula (I) with anti-cancer and/or anti-inflammatory activity and more specifically to azabenzothiophenyl compounds which inhibit MEK kinase activity. The invention provides compositions and methods useful for inhibiting abnormal cell growth or treating a hyperproliferative disorder, or treating an inflammatory disease in a mammal. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.